Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CASP7 | P55210 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CASP4 | P49662 | 1/20 | 0.37 |
| ▸ | CASP5 | P51878 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL19283935 | 0.98 | OGA (0.50) | OGAALDH1A1KDM4ETAAR1CASP1 | |
| SCHEMBL18948987 | 0.83 | ALDH1A1 (0.53) | ALDH1A1KDM4ETAAR1CASP1TSHR | |
| Hydrochloric Acid SCHEMBL25309902 | 0.81 | ALDH1A1 (0.56) | ALDH1A1KDM4ETAAR1CASP1TSHR | |
| SCHEMBL19296234 | 0.80 | OGA (0.57) | OGAALDH1A1KDM4ECYP1A2HSD17B10 | |
| Hydrochloric Acid SCHEMBL19283992 | 0.79 | OGA (0.56) | OGAALDH1A1KDM4ECYP1A2HSD17B10 | |
| SCHEMBL23304816 | 0.76 | ALDH1A1 (0.53) | ALDH1A1KDM4ETAAR1CASP1TSHR | |
| SCHEMBL16651942 | 0.75 | TSHR (0.58) | ALDH1A1KDM4ETAAR1CASP1TSHR | |
| SCHEMBL16651829 | 0.75 | TSHR (0.58) | ALDH1A1KDM4ETAAR1CASP1TSHR | |
| SCHEMBL16651828 | 0.75 | TSHR (0.58) | ALDH1A1KDM4ETAAR1CASP1TSHR | |
| SCHEMBL7991455 | 0.73 | ALDH1A1 (0.59) | ALDH1A1KDM4ETAAR1CASP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3419972-B1 | GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2023-07-26 | — | — | EP | disclosed |
| EP-3419971-B1 | GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2022-04-20 | — | — | EP | disclosed |
| US-20210186958-A1 | GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2021-06-24 | — | — | US | disclosed |
| US-10556902-B2 | Glycosidase inhibitors | ASCENEURON SA (CH) | 2020-02-11 | — | — | US | disclosed |
| US-20190055239-A1 | GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2019-02-21 | — | — | US | disclosed |
| WO-2017144639-A1 | GLYCOSIDASE INHIBITORS | ASCENEURON S. A. (CH) | 2017-08-31 | — | — | WO | disclosed |
| WO-2017144633-A1 | GLYCOSIDASE INHIBITORS | ASCENEURON S. A. (CH) | 2017-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10556902-B2 | Glycosidase inhibitors | ENGASE, GAA, GLA | OGA 69/4885ALDH1A1 716/4885KDM4E 1636/4885 |
| US-20210186958-A1 | GLYCOSIDASE INHIBITORS | ENGASE, GAA, GLA | OGA 73/4885ALDH1A1 635/4885KDM4E 1588/4885 |
| US-20190055239-A1 | GLYCOSIDASE INHIBITORS | ENGASE, GAA, GLA | OGA 69/4885ALDH1A1 716/4885KDM4E 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.